Companies

Study will evaluate whether response to cardiac resynchronization therapy (CRT) may be improved in selected heart failure patients through Tri-V pacing.

Japanese study presented at ESC2015 suggests absorbable stent performs as well as its metallic forebear

Data presented at the ESC Congress 2015 supports St. Jude Medical PressureWire Fractional Flow Reserve technology

Not yet for sale in any market, Twelve’s TMVR system must have impressed the “Irish” titan enough to separate it from approaching half a billion dollars

New financing will accelerate R&D and accelerate global sales and marketing capabilities

St. Jude has gained CE mark approval for its Prodigy MRI™ spinal cord stimulation therapy, the first of its kind to offer MRI compatibility and Burst stimulation

No gazumping here. Thoratec will become part of St. Jude

Particulate matter in the delivery system of Medtronic’s newly FDA approved CoreValve Evolut R system present enough risk to warrant and FDA Class 1 Recall

It looks like ReWalk is enduring that tricky period for any nascent device company, where sales grow, but expenses grow more

Sorin’s Sutureless Valve is in the process of undergoing U.S. FDA approval, but in the meantime is beefing up its international presence with the go-ahed in another market

Strategic alliance will expand Boston Scientific’s portfolio of remote monitoring solutions

Tiny device offers patient benefit of minimal size combined with functionality including sleep apnea monitoring

Lombard says the acquisition expands its product portfolio with the addition of Altura’s ultra-low profile endo stent graft

Coil shapes for every step of procedure combine with new delivery system

Speculative punt or substantiated claim? Who knows?

Bolting on TEI will enhance Integra’s position and allow it to expand into attractive adjacent markets